1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- Basic information
- Product Name:
- 1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-
- Synonyms:
-
- 1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-
- Osimertinib Impurity J
- N-Desdimethylaminoethyl-N-methyl Nitro-N’-desacryloyl Osimertinib
- Osimertinib Impurity 33
- -desacryloylOsimertinib
- N-Desdimethylaminoethyl-N-methylNitro-N&rsquo
- 2-Methoxy-N4,N4-dimethyl-N1-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-5-nitrobenzene-1,4-diamine
- CAS:
- 1820891-36-8
- MF:
- C22H22N6O3
- MW:
- 418.45
- Mol File:
- 1820891-36-8.mol
More
Less
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- Chemical Properties
- Boiling point:
- 668.8±65.0 °C(Predicted)
- Density
- 1.32±0.1 g/cm3(Predicted)
- pka
- 3.10±0.50(Predicted)
More
Less
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- Usage And Synthesis
Uses
N-Desdimethylaminoethyl-N-methyl Nitro-N''-desacryloyl Osimertini are used in the preparation of epidermal growth factor receptors (EGFR) inhibitors as protein tyrosine kinase inhibitors.
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-Supplier
Daicel Chiral Technologies (China)CO.,LTD
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
Beijing Comparison Pharmaceutical Technology Co., Ltd
- Tel
- 010-010-52878169 15801002657
- sales@bjcomparison.com
Zhengzhou Acme Chemical Co., Ltd.
- Tel
- 0371-0371-55629727 13323845623
- 2885676761@qq.com
Shanghai XingTai Pharmaceutical Technology co., LTD
- Tel
- 15801747407
- sales01@suntechpharma.com
Shenzhen Polymeri Biochemical Technology Co., Ltd.
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
More
Less
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-(1820891-36-8)Related Product Information
- 1,2,4-Benzenetriamine, N4-[4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-2-pyrimidinyl]-N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-
- Osimertinib Impurity 7
- Osimertinib Impurity N
- 2-Propenamide, N-[2-[[2-(dimethyloxidoamino)ethyl]methyloxidoamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
- 1,2,4-Benzenetriamine, N4-[4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-2-pyrimidinyl]-5-methoxy-N1-methyl-N1-[2-(methylmethyl-d3-amino)ethyl]-
- AZ-5104
- 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide
- 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-
- Osimertinib mesylate
- Osimertinib Impurity 28
- Osimertinib-13CD3
- 1,2,4-Benzenetriamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-
- Osimertinib Impurity M
- N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
- 4-fluoro-2-methoxy-3-nitrobenzenamine
- AZ 7550